Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on September 23, 2025
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
SARASOTA, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has engaged Fireblocks, an …
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced a successful …
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Offers Leverage, Scalability in Growing Gold Space
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN ( …
Maxus Mining Partners with Palliser Exploration and Commences Project Evaluation of Four Critical Minerals Properties
VANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce the launch of its 2025 exploration partnership with Palliser Exploration Ltd. (“Palliser”) across …
Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
BRIDGEWATER, N.J., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Abbreviated New Drug Application (ANDA) for …
Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating
BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- VanderbiltReport.com, a financial news and content platform, reports that Coeptis Therapeutics (NASDAQ: COEP) is pioneering a dual-track model designed to sustain innovation while reducing reliance on …
Harfang reçoit un avis de Li-FT Power relatif à l'exercice de la deuxième option à Pontax, Québec
MONTRÉAL, 23 sept. 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” ou la “Société”) annonce aujourd’hui avoir reçu un avis de Li-FT Power Ltd. (« LIFT ») (TSX.V : LIFT) confirmant sa décision d’exercer la deuxième option (l’« Avis …
Harfang Receives Notice From Li-FT Power of Advancement To Second Option at Pontax, Quebec
MONTREAL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” or the “Company”) announced today that it has received notice from Li-FT Power Ltd. (“LIFT”) (TSX.V: LIFT) of its decision to proceed with the second option (the …
Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis
Pediatric dosing expected to begin in Q4 2025 Pivotal cohort expected to begin enrolling in Q1 2026 BLA submission anticipated in early 2028 Part A results demonstrated efficacy and safety; ATSN-201 on track to be first gene therapy and one-time treatment …
Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025
BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will host a …
Midland commence un programme de suivi sur ses nouvelles découvertes de minéralisation en or-zinc-argent sur le projet Caniapisc Au à la Baie James
MONTRÉAL, 23 sept. 2025 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland ») (TSX-V : MD) a le plaisir d’annoncer le lancement d’un programme d’exploration de suivi sur ses nouvelles découvertes d’or, de zinc et d’argent sur son projet Caniapisc Au, …
Midland Commences a Follow Up Program on Its New Discovery of Gold-Zinc-Silver Mineralization at The Caniapisc Au Project, James Bay
MONTREAL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the start of a follow-up exploration program on its new discovery of gold, zinc, and silver on its Caniapisc Au project, in the Eeyou …
Altimmune to Participate in Two Upcoming Investor Conferences
GAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the …
BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer
Seasoned AI-Biotech veteran strengthens the company’s leadership in AI and mitochondrial medicine Co-Inventor of AI platform boosts company’s momentum in advancing late-stage assets to commercialization BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- BPGbio Inc …
Aura Declares Commercial Production at Borborema
ROAD TOWN, British Virgin Islands, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (Nasdaq: AUGO) (B3: AURA33) (“Aura” or the “Company”) is pleased to announce that commercial production has been achieved at its Borborema gold mine (“Borborema”) …
Oroco Resource Corp. Announces Live Shareholder Town Hall
VANCOUVER, Canada, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or “the Company”) is pleased to invite shareholders, investors, and stakeholders to a live virtual Town Hall with Executive Chairman, Craig Dalziel …
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients with treatment-resistant depression and demonstrated rapid, clinically meaningful and durable antidepressant effects, which are …
Goliath Completes Over 64,000 Meters Of Drilling in 110 Drill Holes, With 100% Hit Rate In 90 Days On 1.8 Km2 Surebet Gold Discovery That Remains Open, Golddigger Property, Golden Triangle, B.C.
With over 64,000 meters drilled in 110 holes with 9 drill rigs turning for most of the season, the 2025 drill program on Surebet has exceeded the planned 60,000 meters. In what is one of the largest helicopter supported drill programs in challenging alpine …
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 202…
Semnur’s shares of common stock and warrants are expected to trade on the OTC Markets on September 23, 2025 under the ticker symbols “SMNR” and “SMNRW”, respectively. Scilex (together with its affiliates) owns approximately 87.5% of Semnur common stock …
NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- NeuraClick, Inc., an innovative, preclinical-stage biopharmaceutical company reimagining patient health through the development of novel, long-acting neurotherapeutics, today announced the appointment of …